HMRLignan may offer cardiovascular protection

By staff reporter

- Last updated on GMT

Related tags Inflammation

Linnea's HMRLignan, the plant lignan isolated and purified from the
Norway spruce (picea abies), reduced markers of
inflammation linked to heart disease, says new research from Italy.

"This study shows remarkable potential for the inclusion of HMR in a cardiovascular protective regimen,"​ said researcher Marco Cosentino from the University of Insubria in Italy. The data has been released by Switzerland-based Linnea, and indicates that the lignan (7-hydroxymatairesinol) was effective in reducing production of tumour necrosis factor (TNF)-alpha, a marker for inflammation by about 88 per cent, and also inhibited the production of reactive oxygen species from a type of white blood cells. Robin Ward, vice president, commercial operations at Linnea told that the full study would be published in a peer-review journal in the autumn, although the journal has not yet been selected. has not seen the full data. Lignans have a weak oestrogen-like activity and in humans 7-hydroxymatairesinol is converted into a mammalian lignan called enterolactone. Epidemiological studies have linked enterolactone to a reduced risk of certain hormone-related health conditions including breast cancer and cardiovascular disease. "These results indicate that HMR and [its metabolite] enterolactone exert effects that may result in reduction of the inflammatory process, known to be a contributing factor in the etiology of heart disease,"​ said Cosentino. "Tumour necrosis factor production by monocytes infiltrating atherosclerotic lesions is a key factor in the genesis and progression of vascular damage, and oxidative stress of the vascular wall sustained by circulating activated [polymorphonuclear leukocytes] PMNs is an early step in the cascade leading to cardiovascular pathology in otherwise asymptomatic individuals,"​ he said. Cosentino and co-workers investigated the anti-inflammatory properties of HMRlignan and enterolactone on the production of TNF-a in the human cell line THP-1, and found a dose-dependent response with increasing concentrations linked to lower TNF-a levels. Indeed, the preliminary data shows that at a dose of 300 micromoles, HMR reduced TNF-a levels by about 88 per cent, while the same concentration of enterolactone led to an approximate 45 per cent reduction. The production of reactive oxygen species, as a measure of fluorescence, also revealed a dose-dependent response with respect to HMRlignan concentration. "The results of this study add to existing data suggesting that higher dietary lignan intake and enterolactone levels in the blood stream correlate withreduced risk of coronary heart disease-related and cardiovascular-disease-related mortality,"​ commented Donald Brown, a leading US expert on evidence-based herbals. Chronic inflammation, brought about by an over-expression or lack of control of the normal protective mechanism, can lead to a range of inflammatory related disease, particularly cardiovascular disease, the leading cause of death in Europe. Ward also revealed that the company is pushing on with further research in this area: "We are currently recruiting for a human clinical in the USA. In the study we will be looking at C Reactive Protein, LDL-cholesterol, HDL-cholesterol, LDL/HDL ratio and antioxidant free radical scavenging capacity in vivo,"​ he said.

Related news

Show more

Related products

show more

New Study for Female Athletes

New Study for Female Athletes

Content provided by Gencor | 19-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

The Art of Organic Certification

The Art of Organic Certification

Content provided by FoodChain ID | 09-Oct-2023 | White Paper

The organic food market has experienced remarkable growth over the past decade, providing a major opportunity for food brands and manufacturers to tap...

An Insights-driven Holistic Approach to Health

An Insights-driven Holistic Approach to Health

Content provided by Lipofoods, a Lubrizol Company | 25-Sep-2023 | Product Brochure

As they adopt the notion of holistic health, proactive consumers are driving the demand for products that have science-backed ingredients and offer sensory...

Golden Omega® Sustainability Strategy

Golden Omega® Sustainability Strategy

Content provided by LEHVOSS Nutrition | 11-Sep-2023 | Data Sheet

Commitment to sustainability at Golden Omega® is ever growing as they continue to put objectives in place to secure a better environment for the future....

Related suppliers

Follow us


View more